← Eichor
Condition: Ad Mci Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ad Mci

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistic
NA · 1 location(s) · HudsonAlpha Institute for Biotechnology · NCT07146412Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
NA · 1 location(s) · Natalie Denburg · NCT03954899A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 143 location(s) · Hoffmann-La Roche · NCT07169578δ in Dementia Clinical Trials
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT05592678Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain F
NA · 1 location(s) · Boston University Charles River Campus · NCT07659964A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
NA · 1 location(s) · Arizona State University · NCT05877196Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's
Phase 2 · 1 location(s) · Bernard (Barry) Baumel · NCT07512362Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Phase 1 · 1 location(s) · National University Hospital, Singapore · NCT07210528Multimodal Assesment of Alzheimer Patients
Phase N/A · 1 location(s) · Norwegian University of Science and Technology · NCT06448403Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
NA · 1 location(s) · Wake Forest University Health Sciences · NCT03472664A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Ear
NA · 1 location(s) · Weill Medical College of Cornell University · NCT05081596Mindfulness for Cognition in Early-stage Alzheimer's Disease
NA · 1 location(s) · VA Boston Healthcare System · NCT06792877Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCo
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06582199The Swedish BioFINDER - Preclinical AD Study
Phase N/A · 1 location(s) · Skane University Hospital · NCT06121544Music Therapy for Patients With Alzheimer's Disease
NA · 1 location(s) · Johns Hopkins University · NCT05151562Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's D
Phase 2 · 1 location(s) · Medical University of Lodz · NCT06850597Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT07089303Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease
Phase N/A · 1 location(s) · Hanze University of Applied Sciences Groningen · NCT06508268An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
Phase 3 · 2 location(s) · University College, London · NCT07724132PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
Phase 1 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT07169630A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participant
Phase 1 · 1 location(s) · Amyloid Solution Inc · NCT06786676Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
Phase 4 · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT07604896FACE Phase II (a Stage II Trial)
Phase 1/Phase 2 · 1 location(s) · Stanford University · NCT07130669Fisetin in Mild Alzheimer's Disease
Phase 2 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07279714Senicapoc in Alzheimer's Disease
Phase 2 · 2 location(s) · University of California, Davis · NCT04804241A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 150 location(s) · Hoffmann-La Roche · NCT07170150Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NA · 1 location(s) · Mayo Clinic · NCT02740634Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal
NA · 3 location(s) · Deepsonbio · NCT07239310Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Phase 3 · 211 location(s) · Hoffmann-La Roche · NCT07177352
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.